Literature DB >> 6241887

The hypertrophied myocardium accumulates the MB-creatine kinase isozyme.

J S Ingwall.   

Abstract

Myocardial hypertrophy was produced in the dog by volume overload, secondary to hypertension, and pressure overload to left or right ventricles and in the rat by pressure overload to the left or right ventricles, by elevating thyroxine-levels and secondary to spontaneous hypertension in order to test whether there are changes in the creatine kinase system in hypertrophied heart. Although there was little or no change in total creatine kinase activity, there were changes in the distribution of the creatine kinase isozymes. In the dog, a 4-10-fold increase in the tissue content of MB-creatine kinase was observed for heart chambers with a 40-90% increase in the ratio of ventricular weight to body weight. In the rat, MB-creatine kinase also accumulated in hypertrophied ventricles. For the spontaneously hypertensive rat, the correlation between increased fetal creatine kinase isozymes and increased ratio of ventricular weight to body weight was excellent (r approximately 0.92). During the transition from compensated hypertrophy to failure in the spontaneously hypertensive rat, there is a 50% decrease in mitochondrial creatine kinase activity. P-31 NMR magnetization transfer experiments suggest that flux through the creatine kinase reaction is 3-fold lower than normal in these failing hearts. These results show that there are changes in the distribution of the creatine kinase isozymes in hypertrophied heart and suggest that one of these changes characterizes compensated hypertrophy (increased fetal-type creatine kinase isozymes) while another characterizes the transition to failure (decreased mitochondrial creatine kinase).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6241887     DOI: 10.1093/eurheartj/5.suppl_f.129

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

Review 1.  Energy metabolism in heart failure and remodelling.

Authors:  Joanne S Ingwall
Journal:  Cardiovasc Res       Date:  2008-11-05       Impact factor: 10.787

2.  Heterogeneous cellular expression of creatine kinase isoenzyme during normal rat heart development.

Authors:  R T Dowell; M C Fu
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

3.  Thyroxine-induced redistribution of creatine kinase isoenzymes in rat cardiomyocyte cultures.

Authors:  H Brik; L Alkaslassi; D Harell; O Sperling; A Shainberg
Journal:  Experientia       Date:  1989-06-15

4.  Post-infarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium.

Authors:  C D Hoang; J Zhang; R M Payne; F S Apple
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

5.  Changes in myosin and creatine kinase mRNA levels with cardiac hypertrophy and hypothyroidism.

Authors:  G T Schuyler; L R Yarbrough
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

Review 6.  Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.

Authors:  Sanford P Bishop; Jianyi Zhang; Lei Ye
Journal:  Biology (Basel)       Date:  2022-06-08

Review 7.  Creatine kinase in the dog: a review.

Authors:  M Aktas; D Auguste; H P Lefebvre; P L Toutain; J P Braun
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

8.  Proteomic analysis of Rac1 transgenic mice displaying dilated cardiomyopathy reveals an increase in creatine kinase M-chain protein abundance.

Authors:  Nina Buscemi; Amanda Doherty-Kirby; Mark A Sussman; Gilles Lajoie; Jennifer E Van Eyk
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

9.  Bioenergetic abnormalities associated with severe left ventricular hypertrophy.

Authors:  J Zhang; H Merkle; K Hendrich; M Garwood; A H From; K Ugurbil; R J Bache
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 10.  Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy.

Authors:  Mark A Peterzan; Andrew J M Lewis; Stefan Neubauer; Oliver J Rider
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.